Skip to content
10-K

Annual Report

Fulgent Genetics, Inc. FLGT

0000950170-25-029512

← back to feed
Filed
Feb 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 24, 2025 30.83M sh
Stockholders Equity FY 2024 · Dec 31, 2023 $1.14B
Current Liabilities FY 2024 · Dec 31, 2023 $73.02M
Total Liabilities FY 2024 · Dec 31, 2023 $102.04M
Current Assets FY 2024 · Dec 31, 2023 $507.85M
Total Assets FY 2024 · Dec 31, 2023 $1.24B
Shares Diluted FY 2024 · Dec 31, 2022 30.96M sh
Stock Repurchased FY 2024 · Dec 31, 2022 $74.34M
Capex FY 2024 · Dec 31, 2022 $18.78M
Operating Cash Flow FY 2024 · Dec 31, 2022 $253.52M
Cash And Equivalents FY 2024 · Dec 31, 2022 $79.51M
Sga Expense FY 2024 · Dec 31, 2022 $111.07M
Rd Expense FY 2024 · Dec 31, 2022 $28.91M
Net Income FY 2024 · Dec 31, 2022 $143.4M
Operating Income FY 2024 · Dec 31, 2022 $178.53M
Gross Profit FY 2024 · Dec 31, 2022 $366.9M
Cost Of Revenue FY 2024 · Dec 31, 2022 $252.07M
Revenue FY 2024 · Dec 31, 2022 $618.97M